Skip to main content
. Author manuscript; available in PMC: 2022 May 27.
Published in final edited form as: J Clin Lipidol. 2017 Sep 1;11(6):1354–1360.e3. doi: 10.1016/j.jacl.2017.08.013

Table 4:

One-year follow-up controlled for baseline and change in traditional risk factors and change in gynoid fat

Table 4: n = 498 ΔMAP (mmHg) ΔSEVR ΔFMD (%)
β p-value β p-value β p-value
ΔBMI (kg/m2) −0.013 0.776 −0.166 <0.001 −0.248 <0.001
ΔAndroid:Gynoid Ratio −0.011 0.823 −0.131 0.006 −0.124 0.009
ΔAndroid Fat (kg) 0.045 0.339 −0.124 0.009 −0.124 0.009

Multivariate analyses of one-year change were controlled for gender, ethnicity, tobacco use at baseline, baseline age, baseline hypertension, baseline diabetes, change in tobacco use at one year, change in HDL, change in total cholesterol, change in gynoid fat mass, and new statin, antihypertensive, or diabetic medication use after one year.